eubiologics is a company dedicated to contributing to human health throughout life, with a primary focus on the development and manufacturing of vaccines. Its key product is an oral cholera vaccine called "Euvichol," which is supplied worldwide, including to developing countries, through WHO (World Health Organization) and UNICEF. The company plays a crucial role in WHO's 'Global Roadmap to End Cholera by 2030' through close collaboration with the Bill & Melinda Gates Foundation. In addition to the cholera vaccine, the company has a robust pipeline that includes vaccines for COVID-19, meningococcal disease, typhoid, RSV (Respiratory Syncytial Virus), shingles, and Alzheimer's, developed using its proprietary platform technology.

EulMTTM (EuBiologics Immune Modulation Technology) : MPLA Manufacturing Technology in order to maximize the immune response by activating the immune system in the body EuVCTTM (EuBiologics Vaccine Conjugation Technology) : Development of recombinant CRM197 (rCRM197) that increases yield more than tentimes compared to the natural form CRM197

Public

Biotech, CDMO, R&D Service